Low tumor cell density environment yields survival advantage of tumor cells exposed to MTX in vitro

Biochimica et Biophysica Acta - General Subjects

Volumn 1721, Issue 1-3, 2005, Pages 98-106

  De Anta, Josep M ^a,b   Real, Francisco X ^a,c   Mayol, Xavier ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Facultat Geol Univ B   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Cell survival G04.335.316 ; Cultured A11.251.210.770 ; Drug resistance; Neoplasm; Neoplasm G12.392.395 ; Nucleoside D13.570 ; Residual C04.697.700 ; Tumor cell

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOXANTHINE; METHOTREXATE; NUCLEOSIDE; THYMIDINE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL DEATH; CELL DENSITY; CELL POPULATION; CELL SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; TUMOR CELL;

ADAPTATION, PHYSIOLOGICAL; ANTIMETABOLITES, ANTINEOPLASTIC; CELL COUNT; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HT29 CELLS; HUMANS; METHOTREXATE; NEOPLASMS; OSTEOSARCOMA;

EID: 11844252002     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.10.006     Document Type: Article

References (33)

1. A.R. Kinsella, D. Smith, and M. Pickard Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage Br. J. Cancer 75 1997 935 945
2. A. Lorico, G. Toffoli, M. Boiocchi, E. Erba, M. Broggini, G. Rappa, and M. D'Incalci Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5, 8-dideazafolic acid Cancer Res. 48 1988 2036 2041
3. V.T. DeVita, S. Hellman, and S.A. Rosenberg Cancer: Principles and Practice of Oncology Lippincott 2001 Williams and Wilkins Philadelphia
4. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164
5. C. Ma, S. Martin, B. Trask, and J.L. Hamlin Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells Genes Dev. 7 1993 605 620
6. A. Almasan, P. Linke, T.G. Paulson, L.C. Huang, and G.M. Wahl Genetic instability as a consequence of inappropriate entry into and progression through S-phase Cancer Metastasis Rev. 14 1995 59 73
7. A. Coquelle, E. Pipiras, F. Toledo, G. Buttin, and M. Debatisse Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons Cell 89 1997 215 225
8. P. Kantharidis, A. El-Osta, M. deSilva, D.M. Wall, X.F. Hu, A. Slater, G. Nadalin, J.D. Parkin, and J.R. Zalcberg Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance Clin. Cancer Res. 3 1997 2025 2032
9. Y. Tada, M. Wada, K. Kuroiwa, N. Kinugawa, T. Harada, J. Nagayama, M. Nakagawa, S. Naito, and M. Kuwano MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment Clin. Cancer Res. 6 2000 4618 4627
10. D. Banerjee, P. Mayer-Kuckuk, G. Capiaux, T. Budak-Alpdogan, R. Gorlick, and J.R. Bertino Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase Biochim. Biophys. Acta 1587 2002 164 173
11. G. Weber, M. Nagai, Y. Natsumeda, S. Ichikawa, H. Nakamura, J.N. Eble, H.N. Jayaram, W.N. Zhen, E. Paulik, R. Hoffman, and G. Tricot Regulation of de novo and salvage pathways in chemotherapy Adv. Enzyme Regul. 31 1991 45 67
12. R. Goel, and S.B. Howell Modulation of the activity of cancer chemotherapeutic agents by dipyridamole F.M. Muggia New Drugs, Concepts and Results in Cancer Chemotherapy 1992 Kluber Academic Publishers Boston 19 44
13. Y.S. Zhen, T. Taniki, and G. Weber Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells Oncol. Res. 4 1992 73 78
14. P.D. Cole, A.K. Smithand, and B.A. Kamen Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs Cancer Chemother. Pharmacol. 50 2002 111 116
15. T. Lesuffleur, A. Barbat, E. Dussaulx, and A. Zweibaum Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells Cancer Res. 50 1990 6334 6343
16. T. Lesuffleur, A. Barbat, C. Luccioni, J. Beaumatin, M. Clair, A. Kornowski, E. Dussaulx, B. Dutrillaux, and A. Zweibaum Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells J. Cell Biol. 115 1991 1409 1418
17. M. de Nonancourt-Didion, J.-L. Guéant, C. Adjalla, C. Chéry, R. Hatier, and F. Namour Overexpression of folate binding protein a is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate Cancer Lett. 171 2001 139 145
18. T. Lesuffleur, S. Violette, I. Vasile-Pandrea, E. Dussaulx, A. Barbat, M. Muleris, and A. Zweibaum Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype Int. J. Cancer 76 1998 383 392
19. J.L. Ward, A. Sherali, Z.P. Mo, and C.M. Tse Kinetics and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells J. Biol. Chem. 275 2000 8375 8381
20. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instabilities in human cancers Nature 396 1998 643 649
21. W. Li, J. Fan, D. Hochhauser, D. Banerjee, Z. Zielinski, A. Almasan, Y. Yin, R. Kelly, G.A. Wahl, and J.R. Bertino Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines Proc. Natl. Acad. Sci. U. S. A. 92 1995 10436 10440
22. S.B. Howell, S.J. Mansfield, and R. Taetle Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate Cancer Chemother. Pharmacol. 5 1981 221 226
23. Ż. Smoleńska, Z. Kaznowska, D. Zarówny, H.A. Simmonds, and R.T. Smoleński Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis Rheumatology 38 1999 997 1002
24. A.F. Sobrero, and J.R. Bertino Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum Int. J. Cell Cloning 4 1986 51 62
25. J.M. Hughes, A. deFazio, and M.H. Tattersall Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay Br. J. Cancer 57 1988 459 463
26. M.G. Rots, R. Pieters, G.J. Kaspers, C.H. van Zantwijk, P. Noordhuis, R. Mauritz, A.J. Veerman, G. Jansen, and G.J. Peters Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay Blood 93 1999 1067 1074
27. M. Pastor, A. Anglada, and F.J. Felipe Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies Trends Pharmacol. Sci. 19 1998 424 430
28. S.A. Baldwin, J.R. Mackey, C.E. Cass, and J.D. Young Nucleoside transporters: molecular biology and implications for therapeutic development Mol. Med. Today 5 1999 216 224
29. J. Pressacco, B. Mitrovski, C. Erlichman, and D.W. Hedley Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression Cancer Res. 55 1995 1505 1508
30. J. Pressacco, J.S. Wiley, G.P. Jamieson, C. Erlichman, and D.W. Hedley Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis Br. J. Cancer 72 1995 939 942
31. R. Valdés, M.A. Ortega, F.J. Casado, A. Felipe, A. Gil, A. Sanchez-Pozo, and M. Pastor-Anglada Nutritional regulation of nucleoside transporter expression in rat small intestine Gastroenterology 119 2000 1623 1630
32. R. Valdés, F.J. Casado, and M. Pastor-Anglada Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugs Biochem. Biophys. Res. Commun. 296 2002 575 579
33. T. Takechi, K. Koizumi, H. Tsujimoto, and M. Fukushima Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumour cells, Jpn J. Cancer Res. 92 2001 696 703